About
Kevin Dai, Pharm.D, BCOP, joined Vivo with healthcare and sell side equity research experience. Prior to Vivo, Kevin worked at Memorial Sloan Kettering Cancer Center for 3 years as a Clinical Oncology Pharmacy Specialist in the hematology department, where he provided direct patient care and managed all active clinical trials within the leukemia department. He then worked at Canaccord Genuity as an equity research associate covering small to large cap biotechnology and specialty pharmaceutical companies. Additionally, Kevin interned at Merck & Co. in the ion channel department, where his research has been published in multiple medical journals, including Biochemistry, PNAS, and Bone Marrow Transplantation. Kevin received a Pharm.D from Ernest Mario School of Pharmacy at Rutgers. He then completed his internal medicine residency at University of Chicago Medical Center and his oncology residency at Memorial Sloan Kettering Cancer center. He is a board certified oncology pharmacist (BCOP
Position in the VCSift Database
- • 16 investors at Vivo Capital are tracked.
- • 1,801 investors hold the Managing Director role in VCSift. Kevin Dai is one of them.
- • 7,285 investors are based in San Francisco, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- San Francisco, US
Contact Information
Find more investors like Kevin
Search Investors